<DOC>
	<DOCNO>NCT00233623</DOCNO>
	<brief_summary>The aim study determine Iressa add chemotherapy Irinotecan , 5Fluorouracil Leucovorin prolong period time without disease worsening ( Time Progression ) patient metastatic colorectal cancer .</brief_summary>
	<brief_title>Irinotecan , 5-Fluorouracil Leucovorin With Without Iressa Treatment Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologically confirm metastatic colorectal cancer Presence measurable metastases No previous treatment metastatic cancer No presence Central Nervous System metastases No coexist malignancy malignancy diagnose within last 5 year exception basal cell carcinoma cervical cancer situ Any evidence severe uncontrolled systemic disease ( e.g . unstable uncompensated respiratory , cardiac , hepatic renal disease )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Metastatic Colorectal Cancer</keyword>
</DOC>